伴同性動物診斷市場規模、佔有率、成長分析、按技術、按動物類型、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年，伴同性動物診斷的全球市場規模為23億美元，從2023年的25.3億美元成長到2031年的53.4億美元，在預測期內（2024-2031年）預計將以複合年成長率成長。 9.8%。

寵物慢性病盛行率的上升和診斷技術的進步預計將推動伴同性動物診斷市場的顯著成長。據報道，從2012年到2022年，狗的糖尿病將增加40%，貓的糖尿病將增加30%，迫切需要有效的診斷。寵物擁有量的增加進一步推動了這個市場，超過 6,390 萬家庭擁有至少一隻狗，約 5,200 萬個家庭擁有一隻貓。此外，對自動化和半自動化診斷測試的需求正在迅速增加，從而提高了樣品處理的效率。照護端診斷 (POCD) 等創新有望快速取得成果，而旨在改善獸醫服務的政府舉措將支持長期市場擴張。到 2031 年，美國的動物保健費用預計將達到 330 億美元。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特分析與影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 案例研究

伴同性動物診斷市場規模：依技術分類

• 市場概況
• 臨床生物化學
  • 臨床化學分析
  • 試劑夾盒
  • 分析儀
  • 血糖監測
  • 血糖值測試紙
  • 血糖值監測儀
  • 尿糖測試紙
  • 血氣電解質分析
  • 試劑夾盒
  • 血氣/電解質分析儀
• 免疫診斷
  • 橫向流動化驗
  • 快速測試
  • 條帶龍頭（側向流讀取儀）
  • 酵素連結免疫吸附試驗
  • 過敏特異性免疫診斷測試
  • 免疫檢測分析儀
  • 其他免疫診斷動物類型
• 血液學
  • 墨水匣
  • 分析儀
• 尿液檢查
  • 夾子和墨盒/面板
  • 尿液分析儀
  • 尿液檢查紙條
• 分子診斷
  • 聚合酵素鏈鎖反應測試
  • 微陣列
  • 其他分子診斷動物物種
• 其他寵物診斷技術

伴同性動物診斷市場規模：依動物類型

• 市場概況
• 狗
• 貓
• 馬
• 其他寵物

伴同性動物診斷市場規模：依應用分類

• 市場概況
• 臨床病理學
• 細菌學
• 病毒學
• 寄生蟲學
• 其他用途

伴同性動物診斷市場規模：依最終用戶分類

• 市場概況
• 診斷實驗室
• 動物醫院/診所
• 研究機構和大學
• 居家照護設置

伴同性動物診斷市場規模：按地區

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Idexx Laboratories, Inc.
• Zoetis Inc.
• Thermo Fisher Scientific Inc.
• Biomerieux SA
• Virbac
• Neogen Corporation
• Fujifilm Holdings Corporation
• Indical Bioscience GmbH
• Idvet
• Randox Laboratories, Ltd.
• Bionote, Inc.
• Skyla Corporation
• Urit Medical Electronic Co., Ltd.
• Nova Biomedical
• Fassisi GmbH
• Swissavans AG
• Alvedia
• Megacor Veterinary Diagnostics
• Biopanda Reagents Ltd
• Anipoc Ltd
• Ring Biotechnology Co Ltd.

結論和建議

Global Companion Animal Diagnostics Market size was valued at USD 2.3 billion in 2022 and is poised to grow from USD 2.53 billion in 2023 to USD 5.34 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2024-2031).

The growing prevalence of chronic disorders in pets, coupled with advancements in diagnostics, is poised to drive significant growth in the companion animal diagnostics market. Reports indicate a staggering 40% rise in canine diabetes and a 30% increase in feline diabetes from 2012 to 2022, reflecting an urgent need for effective diagnostics. The rising number of pet owners further supports this market, with over 63.9 million households owning at least one dog and around 52 million with cats. Additionally, the demand for automated and semi-automated diagnostic testing is surging, enhancing efficiency in sample handling. Innovations such as Point of Care Diagnostics (POCD) promise expedited results, while government initiatives aimed at improving veterinary services underpin long-term market expansion. The U.S. veterinary care expenditure is expected to reach USD 33 billion by 2031.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Companion Animal Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Companion Animal Diagnostics Market Segmental Analysis

Global Companion Animal Diagnostics Market is segmented by Technology, Animal Type, Application, End User, and region. Based on Technology, the market is segmented into Clinical biochemistry, Immunodiagnostics, Hematology, Urinalysis, Molecularity Molecular diagnostics, and Other Companion Animal Diagnostic Technologies. Based on Animal Type, the market is segmented into Dogs, Cats, Horses, and Other companion animals. Based on Application, the market is segmented into Clinical Pathology, Bacteriology, Virology, Parasitology, and Other Applications. Based on End User, the market is segmented into Diagnostic Laboratories, Veterinary Hospitals & Clinics, Research Institutes & Universities, and Home-care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Companion Animal Diagnostics Market

The Global Companion Animal Diagnostics market is witnessing significant growth driven by the increasing demand for rapid testing and portable diagnostic tools designed for point-of-care (PoC) services. These tools have become essential for veterinarians, facilitating the quick detection of animal illnesses, particularly in remote locations like homes or shelters, and during emergencies. Major manufacturers are focusing on developing innovative portable diagnostics that enhance workflow in veterinary hospitals and research institutions. Additionally, pet healthcare spending, including veterinary treatments and pet insurance, has surged, encouraging pet owners, especially in North America and Europe, to invest in comprehensive care for their animals. This surge in demand for efficient, cost-effective diagnostic solutions underpins the expansion of the market.

Restraints in the Global Companion Animal Diagnostics Market

The growth of the Global Companion Animal Diagnostics market may be hindered by escalating pet care expenses, particularly in developing nations where there is a shortage of veterinarians. These rising costs could deter pet owners from seeking necessary diagnostic services, ultimately impacting market expansion. Additionally, a general lack of awareness regarding animal healthcare poses a substantial challenge, preventing pet owners from recognizing the importance of regular diagnostics. Collectively, these factors will likely create significant obstacles for the companion animal diagnostics market during the projected period, impeding its potential for growth and advancement.

Market Trends of the Global Companion Animal Diagnostics Market

The Global Companion Animal Diagnostics market is witnessing a significant trend driven by heightened research and development efforts focused on the diagnostic capabilities for companion animals, especially in relation to SARS-CoV-2 exposure. As various animal species emerge as potential vectors for COVID-19, key health organizations, including the CDC and USDA, are actively engaging in monitoring and studying these vulnerabilities. This surge in research not only enhances understanding of the epidemiological impact on animal and human health but also stimulates innovation in diagnostic devices. Consequently, the market is anticipated to expand, reflecting an increased demand for advanced diagnostic solutions that ensure better health outcomes for companion animals.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Companion Animal Diagnostics Market Size by Type & CAGR (2024-2031)

• Market Overview
• Clinical biochemistry
  • Clinical chemistry analysis
  • Reagents, clips, and cartridges
  • Analyzers
  • Glucose monitoring
  • Blood glucose strips
  • Glucose monitors
  • Urine glucose strips
  • Blood gas electrolyte analysis
  • Reagents, clips, and cartridges
  • Blood gas & electrolyte analyzers
• Immunodiagnostics
  • Lateral flow assays
  • Rapid tests
  • Strip readers (Lateral flow readers)
  • Elisa tests
  • Allergen-specific immunodiagnostic tests
  • Immunoassay analyzers
  • Other immunodiagnostic Animal Types
• Hematology
  • Cartridges
  • Analyzers
• Urinalysis
  • Clips & cartridges/panels
  • Urine Analyzers
  • Urine test strips
• Molecular diagnostics
  • Polymerase chain reaction tests
  • Microarrays
  • Other molecular diagnostic Animal Types
• Other Companion Animal Diagnostic Technologies

Global Companion Animal Diagnostics Market Size by Animal Type & CAGR (2024-2031)

• Market Overview
• Dogs
• Cats
• Horses
• Other companion animals

Global Companion Animal Diagnostics Market Size by Application & CAGR (2024-2031)

• Market Overview
• Clinical Pathology
• Bacteriology
• Virology
• Parasitology
• Other Applications

Global Companion Animal Diagnostics Market Size by End User & CAGR (2024-2031)

• Market Overview
• Diagnostic Laboratories
• Veterinary Hospitals & Clinics
• Research Institutes & Universities
• Home-care Settings

Global Companion Animal Diagnostics Market Size & CAGR (2024-2031)

• North America (Technology, Animal Type, Application, End User)
  • US
  • Canada
• Europe (Technology, Animal Type, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Technology, Animal Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Technology, Animal Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Animal Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Idexx Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indical Bioscience GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Idvet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionote, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Skyla Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Urit Medical Electronic Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fassisi GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Swissavans AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvedia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Megacor Veterinary Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopanda Reagents Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anipoc Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ring Biotechnology Co Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation